Zantac Update: FDA Recalls All Ranitidine From Market

Zantac Update: FDA Recalls All Ranitidine From Market

On Wednesday, April 1, 2020, the U.S. Food and Drug Administration requested that manufacturers recall all prescription and OTC ranitidine drugs from the market immediately. The agency has determined that an impurity increases over time, particularly in warm storage temperatures, resulting in unacceptable exposure to the carcinogen NDMA. While some samples tested did not contain…

Zantac Recall featured image showing a man clutching his chest after eating food triggering his heartburn

Zantac Recall Linked to Carcinogen Impurity

Zantac was voluntarily pulled from shelves as a “precautionary measure” after it was determined that more safety assessments are needed after 1,500 samples tested positive for a carcinogen impurity. Ranitidine (Zantac) is an H2 blocker used to treat heartburn. It has been on the market since 1981. Doctors write 15 million prescriptions of Zantac a…